References
- Jin M., Wilhelm M. J., Lang R. E., Unger T., Lindpainter K., Ganten D. Endogenous tissue renin-angiotensin systems. Am. J. Med. 1988; 84: 28–36
- Cody R. J., Jr, Rodgers R., Burton J., Hartley L. H., Herd J. A. Acute renin-dependent hypertension in a nonhuman primate. Response to sodium depletion and converting enzyme inhibition. Hypertension 1982; 4: 219–255
- Wood J. M., Gulati N., Michel J-B., Hofbauer K. G. Two-kidney, one clip renal hypertension in the marmoset. J. Hypertens 1986; 4: 251–254
- Neisius D., Wood J. M. Antihypertensive effect of a renin inhibitor in marmosets with a segmental renal infarction. J. Hypertens 1987; 5: 721–725
- McGill H. C., Jr, Carey K. D., McMahan A., Marinez Y. N., Cooper T. E., Mott G. E., Schwartz C. J. Effects of two forms of hypertension on atherosclerosis in the hyperlipidemic baboon. Atherosclerosis 1985; 5: 481–493
- DeForrest J. M., Scalese R. J., Oehl R. S., Waldron T. L., Mitch S., Brittain R. J., Free C. A., Asaad M., Burkett D. Perinephritis hypertension in Macaca fascicularis (cynomolgus monkey): studies of the renin-angiotensin aldosterone and renal hemodynamic function. Hypertension 1989; 7: 763–767
- Kleinert H. D., Martin D., Chekal M., Young G., Rosenberg S., Plattner J. J., Perun T. J. Cardiovascular actions of the primate selective renin inhibitor, A-62198. J. Pharmacol. Exp. Ther. 1988; 246: 975–979
- Scalese R. J., Deforrest J. M., Parente E. J., Waldron T. L., Oehl R. C., Mitlh S., Free C., Asaad M., Burkett D. Chronically catheterized macque fascicularis (cynomolgus): effects of captopril in sodium-deplete animals. FASEB J. 1989; 3: 1314
- Kleinert H. D., Martin D., Chekal M. A., Kadam J., Luly J. R., Plattner J. J., Perun T. J., Luther R. R. Effects of renin inhibitor A-64662, in monkeys and rats with varying baseline plasma renin activity. Hypertension 1988; 11: 613–619
- Preibisz J. J., Sealey J. E., Aceto R. M., Laragh J. H. Plasma renin activity measurements: an update. Cardiovasc. Res. Rep. 1982; 3: 787–804
- Nussberger J., Brunner D. B., Waeber B., Brunner H. R. True versus immunoreactive angiotensin II in human plasma. Hypertension 1985; 71(Suppl I)11–17
- Mizuno K., Nakamura M., Higaskimori K., Inagami T. Local generation and release of angiotensin II in peripheral vascular tissue. Hypertension 1988; 22: 223–29
- Goldblatt H. Studies on experimental hypertension Ill: The production of persistent hypertension in monkeys (macque) by renal ischemia. J. Exp. Med. 1937; 65: 671–675
- Ledingham J. M. Experimental and renal hypertension. Clin. Nephrol. 1975; 4: 127–137
- Atkinson A. B., Brown J. J., Fraser R., Hever A. F., Morton J. J., Riegger A. J. G., Robertson J. I. S. Angiotensin II and renal hypertension in dog, rat, and man: Effect on converting enzyme inhibition. Clin. Exp. Hypertens 1980; [A]2: 499–524
- Lupu A. N., Maxwell M. H, Kaufman J. J. Mechanisms of hypertension during the chronic phase of the one-clip, two-kidney model in the dog. Circ. Res. 1977; 40(Suppl I)157–161
- Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 1980; 32: 1–46
- Mullane K. M., Moncada S. Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment. Eur. J. Pharmacol. 1980; 66: 355–365
- Wood J. M., Baum H-P., Jobber R. A., Neisius D. Sustained reduction In blood pressure during chronic administration of a renin inhibitor to normotensive marmosets. J. Cardiovasc. Pharmacol. 1987; 10(Suppl 7)596–598
- Wood J. M., Criscione L., DeGasparo M., Bühmayer P., Rüeger H. CGP 38, 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity. J. Cardiovasc. Pharmacol. 1989; 14: 221–226
- Wood J. M., Gulati N., Forgiarini P., Fuhrer W., Hofbauer K. G. Effects of a specific and long-acting renin inhibitor in the marmoset. Hypertension 1985; 7: 797–803